Gossamer Bio, Inc. logo

Gossamer Bio, Inc.

NASDAQ:GOSS

Overview | Financials
Company Name Gossamer Bio, Inc.
Symbol GOSS
Currency USD
Price 0.91
Market Cap 205,866,570
Dividend Yield 0%
52-week-range 0.453 - 1.6
Industry Biotechnology
Sector Healthcare
CEO Mr. Faheem Hasnain
Website https://www.gossamerbio.com

An error occurred while fetching data.

About Gossamer Bio, Inc.

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and

Related Stocks

Pharvaris N.V. logo

Pharvaris N.V.

PHVS

19.12 USD

Kiniksa Pharmaceuticals, Ltd. logo

Kiniksa Pharmaceuticals, Ltd.

KNSA

24.93 USD

Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc.

RANI

2.62 USD

Inogen, Inc. logo

Inogen, Inc.

INGN

11.3 USD

Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc.

RLMD

2.4 USD

PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc.

PMVP

1.5 USD

Aveanna Healthcare Holdings Inc. logo

Aveanna Healthcare Holdings Inc.

AVAH

5.42 USD

Financials

Numbers are in millions USD

Numbers are in millions USD